Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$3.6 - $11.2 $36,000 - $112,000
-10,000 Reduced 1.27%
777,026 $3.37 Million
Q1 2022

May 11, 2022

BUY
$8.58 - $17.65 $6.75 Million - $13.9 Million
787,026 New
787,026 $9.16 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Telemark Asset Management, LLC Portfolio

Follow Telemark Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemark Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemark Asset Management, LLC with notifications on news.